PharmaBoardroom

Chuan Lin – Chairman, TTY Biopharm, Taiwan

Chuan Lin, chairman of TTY Biopharm, one of Taiwan’s leading domestic biomedical players, highlights his ambition to lead the local success story…

Chengdu: The First Steps Towards Mutual Insurance In China

Better known for its panda sanctuary and spicy local cuisine, Chengdu could be the first Chinese city to offer mutual health insurance. Eric…

Éric Ducournau – CEO, Pierre Fabre Group

Éric Ducournau, global CEO of Pierre Fabre Group, the second largest dermo-cosmetic company worldwide and the third-largest French pharmaceutical…

Shooting For the Stars: The Evolution in Outcome-Based Payment…

Brendan Shaw* outlines the benefits that greater adoption of outcome-based payment models for medicines can bring, highlights recent successful…

The US Generic Drug Supply Chain: “Standardized,…

Chip Davis is head of the Association for Accessible Medicines (AAM) which advocates for greater uptake of generic and biosimilar drugs in the USA.…

Grace Yeh – President and Founder, PharmaEngine, Inc.,…

Grace Yeh, president and founder of PharmaEngine, gives an update on the company’s recent growth and development of their second nanomedicine cancer…

Ingrid Zhang – President, Novartis Pharmaceuticals China

Ingrid Zhang, president of Novartis Pharmaceuticals China, shares the transformation of Novartis China in the past two years in line with the global…

Francisco Coll – CEO, Quinton, Spain

Francisco Coll, CEO of Quinton, explains the background behind the company’s seawater therapies and how they are expanding this originally French…

Mohamed Mabrouk – CEO, Pharmed Healthcare, Egypt

Dr Mohamed Mabrouk, CEO of Pharmed Healthcare, highlights how the company has evolved from only offering Hepatitis C treatment to having 112 products…

Taiwan-US Research Team in MERS ‘Camel Flu’ Vaccine…

Researchers from Taiwan and the USA may have found a vaccine for the Middle East respiratory syndrome coronavirus (MERS-CoV) – a deadly emerging…

Technology Convergence in the Digital Era: What Implications for…

Pierre Meulien of the Innovative Medicines Initiative (IMI) discusses the potential impact that new technological innovations will have on the drug…

Sweden Pharma R&D Snapshot

Over EUR 1 billion was spent in Sweden on pharmaceutical R&D in 2015, a similar level to spending seen in Italy and Denmark. Made with…

Tagged with